Menu Search
Equities

Healixa Inc

EMOR:PKL

Healixa Inc

Actions
  • Price (USD)0.0809
  • Today's Change0.006 / 7.44%
  • Shares traded140.60k
  • 1 Year change-79.79%
  • Beta--
Data delayed at least 15 minutes, as of May 21 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Healixa, Inc. is a technology company, which is focused on building and acquiring and disruptive technologies in the clean water generation, health-tech, and green-tech industries. The Company is combining its intellectual properties, patents, strategic collaborations, and partnerships to create a LaunchPad of disruptive sustainable products. It creates sustainable technologies for its planet and its people through access to safe drinking water and affordable health care. The Company is also engaged in the creation, acquisition, development and deployment of ethically engineered healing technologies that have a positive impact. This includes technology that has an impact on the macro environmental challenges of its time and health technology that makes quality health care accessible to all people. It also focuses on clean water through its Global AquaDuct atmospheric water harvesting technology. It also owns and operates patient care coordination software and services.

  • Revenue in -- (TTM)--
  • Net income in --
  • Incorporated1977
  • Employees--
  • Location
    Healixa Inc51 Elm StHUNTINGTON 11743United StatesUSA
  • Phone+1 (952) 746-1291
  • Fax+1 (952) 746-1293
  • Websitehttps://www.healixa.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.